UPDATE: Ariad, Zygogen to Jointly Develop Zebrafish Models for Functional Genomics | GenomeWeb

This story has been updated from a previous version.

NEW YORK, May 23 - Ariad Pharmaceuticals and Zygogen have agreed to jointly develop gene regulation technology based on Zygogen's transgenic zebrafish models, the companies said Wednesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.